Iris Hill

Iris Hill is a strategic and tactical C-Level Healthcare Leader with a focus on driving healthcare innovation, strategy, and partnerships from R&D to commercialization in digital environments.

With a proven track record of fueling multimillion-dollar revenue growth, increasing customer acquisition, and securing large project agreements, Iris is dedicated to helping healthcare organizations achieve financial success and market expansion.

She has managed up to $125M P&L and overseen a team of over 100 resources, while establishing and managing healthcare businesses and cultivating strong relationships with various stakeholders.

Her educational background includes studies in Digital Therapeutics, Finance, Prescription Drug Regulation, Corporate Governance, Medical Science, and International Law from renowned institutions.

Iris has held leadership positions like Chairman Of The Board at Bio Alliances, CEO at ObvioHealth, Bio Alliances, and ORCA USA Inc., as well as roles at IQVIA, Teva Pharmaceuticals Ltd., Pharmatop, and various research positions.

Her expertise lies in revenue growth, customer acquisition, project agreements, strategic partnerships, healthcare management, digital therapeutics, finance, corporate governance, and medical science.